AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 167 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $393,000 | +17.7% | 23,498 | +1.4% | 0.01% | 0.0% |
| Q1 2020 | $334,000 | -57.9% | 23,167 | -2.2% | 0.01% | -52.9% |
| Q4 2019 | $793,000 | +120.3% | 23,687 | +37.6% | 0.02% | +112.5% |
| Q3 2019 | $360,000 | +148.3% | 17,210 | +147.3% | 0.01% | +166.7% |
| Q2 2019 | $145,000 | -19.4% | 6,958 | -13.7% | 0.00% | -25.0% |
| Q1 2019 | $180,000 | +56.5% | 8,065 | +67.7% | 0.00% | +33.3% |
| Q4 2018 | $115,000 | – | 4,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,967,900 | $42,933,000 | 29.35% |
| TLP GROUP LLC | 2,833,285 | $30,656,000 | 20.86% |
| Aisling Capital LLC | 2,990,000 | $32,352,000 | 7.64% |
| Vivo Capital, LLC | 763,009 | $8,256,000 | 2.26% |
| RA Capital Management | 1,292,940 | $13,990,000 | 1.94% |
| Foresite Capital Management III, LLC | 235,020 | $2,543,000 | 1.74% |
| Palo Alto Investors LP | 325,599 | $3,523,000 | 0.27% |
| Rock Springs Capital Management LP | 293,000 | $3,170,000 | 0.24% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 332,625 | $3,599,000 | 0.20% |
| Virtus ETF Advisers LLC | 19,501 | $211,000 | 0.16% |